Georges Vauquelin
Free University Brussels (VUB)
Molecular and Biochemical Pharmacology Department
Pleinlaan 2
B-1050 Brussels
Name/email consistency: high
- Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems. Vauquelin, G., Van Liefde, I. Expert. Opin. Drug. Discov (2012)
- Clozapine, atypical antipsychotics, and the benefits of fast-off D(2) dopamine receptor antagonism. Vauquelin, G., Bostoen, S., Vanderheyden, P., Seeman, P. Naunyn Schmiedebergs Arch. Pharmacol. (2012)
- Ligands, their receptors and ... plasma membranes. Vauquelin, G., Packeu, A. Mol. Cell. Endocrinol. (2009)
- Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation. Vauquelin, G., Szczuka, A. Neurochem. Int. (2007)
- Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans. Vauquelin, G., Fierens, F., Van Liefde, I. J. Hypertens. Suppl (2006)
- Slow antagonist dissociation and long-lasting in vivo receptor protection. Vauquelin, G., Van Liefde, I. Trends Pharmacol. Sci. (2006)
- Models and methods for studying insurmountable antagonism. Vauquelin, G., Van Liefde, I., Vanderheyden, P. Trends Pharmacol. Sci. (2002)
- New insights in insurmountable antagonism. Vauquelin, G., Van Liefde, I., Birzbier, B.B., Vanderheyden, P.M. Fundam. Clin. Pharmacol (2002)
- A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists. Vauquelin, G., Morsing, P., Fierens, F.L., De Backer, J.P., Vanderheyden, P.M. Biochem. Pharmacol. (2001)
- The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells. Vauquelin, G., Fierens, F.L., De Backer, J.P., Vanderheyden, P.M. J. Am. Soc. Nephrol. (1999)